These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12399618)

  • 21. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
    Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
    Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E as a functional and biocompatibility modifier of synthetic hemodialyzer membranes: an overview of the literature on vitamin E-modified hemodialyzer membranes.
    Piroddi M; Pilolli F; Aritomi M; Galli F
    Am J Nephrol; 2012; 35(6):559-72. PubMed ID: 22677717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of inflammation on anti-oxidative effects of vitamin E-coated membrane dialyzer in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Efstratiadis G; Memmos D
    Hemodial Int; 2014 Oct; 18(4):751-7. PubMed ID: 24641709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terminating the immune response.
    Marrack P; Scott-Browne J; MacLeod MK
    Immunol Rev; 2010 Jul; 236():5-10. PubMed ID: 20636804
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of effect of vitamin E-coated dialyzer and oral vitamin E on hemodialysis-induced Cu/Zn-superoxide dismutase.
    Akiyama S; Inagaki M; Tsuji M; Gotoh H; Gotoh T; Washio K; Gotoh Y; Oguchi K
    Am J Nephrol; 2005; 25(5):500-6. PubMed ID: 16155359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological biocompatibility characterization of a vitamin E-bonded membrane.
    Girndt M; Kaul H; Lengler S; Sester U; Sester M; Köhler H
    Contrib Nephrol; 1999; 127():226-42. PubMed ID: 10629792
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients.
    Gu Y; Ding F; Qin H; Zhao H; Lin S
    Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients.
    Usberti M; Gerardi G; Bufano G; Tira P; Micheli A; Albertini A; Floridi A; Di Lorenzo D; Galli F
    Am J Kidney Dis; 2002 Sep; 40(3):590-9. PubMed ID: 12200812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune deficiency of the uremic patient.
    Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
    Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte apoptosis: role of uremia and permeability of dialysis membrane.
    Soriano S; Martín-Malo A; Carracedo J; Ramírez R; Rodríguez M; Aljama P
    Nephron Clin Pract; 2005; 100(3):c71-7. PubMed ID: 15824510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of chronic hepatitis C virus infection on T-cell cytokine production in chronic hemodialysis patients.
    Rostaing L; Borde JS; Hasle C; Bories P; Allal A; Abbal M; Durand D
    Am J Nephrol; 2001; 21(3):194-9. PubMed ID: 11423688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bio-incompatibility and Th2 polarization during regular dialysis treatment.
    Libetta C; Sepe V; Dal Canton A
    Int Rev Immunol; 2010 Dec; 29(6):608-25. PubMed ID: 21073329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of vitamin E-bonded polysulfone dialyzer and polysulfone dialyzer on a series of non-anticoagulant hemodialysis.
    Torato T; Doi K; Negishi K; Hamasaki Y; Satonaka H; Hanafusa N; Noiri E
    ASAIO J; 2013; 59(3):284-5. PubMed ID: 23644616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the bioreactivity of vitamin-E-modified dialyzer an expression of increased plasmatic vitamin E concentration?
    Senatore M; Nicoletti A; Rizzuto G
    Nephron; 2002 Oct; 92(2):487-9. PubMed ID: 12218339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of hemodialysis on lung function in patients with end-stage renal disease.
    Lang SM; Becker A; Fischer R; Huber RM; Schiffl H
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):108-13. PubMed ID: 16703255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [T- and B-lymphocyte in chronic glomerulonephritis and uremia].
    Kacprzyk F; Kuźmińska B; Orłwski Z
    Pol Tyg Lek; 1980 Dec; 35(48):1861-4. PubMed ID: 6970927
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune system dysregulation in uremia: role of oxidative stress.
    Descamps-Latscha B; Jungers P; Witko-Sarsat V
    Blood Purif; 2002; 20(5):481-4. PubMed ID: 12207098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.